Short Communication
Bilateral Moorens Ulcer
Tarun Sood, Mandeep Tomar,
Anuj Sharma, Ravinder K. Gupta
Pak J Ophthalmol 2016, Vol. 32 No.
3
. . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . ..
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for authors affiliations …..……………………….. Correspondence to: Tarun Sood M.S. Ophthalmology (IGMC
Shimla) Eye Surgeon Civil Hospital Sarkaghat Himachal Pardesh, India E.mail: tarunsood_86@yahoo.co.in |
A 36 year old male presented with chief
complaints of foreign body sensation watering, redness, diminished vision
ocular pain and photophobia in both eyes for last 2 months, On examination right eye revealed a perforated Mooren ulcer with
uveal tissue herniation at 4 – 5 o’clock position. In both eyes, an
undermined overhanging edge with grey white opacification and extending
centrally and circumferentially could be appreciated. No hypopyon or AC cells
could be discovered on examination, A diagnosis of bilateral Mooren’s ulcer
was made and systemic
immunosuppressive therapy was started in terms of oral methotrexate 10 mg
once a week and oral prednisone 1 mg / kg / day, Bandage Contact Lens was
applied in right eye and conjunctival recession was performed. Key Words: Moorens Ulcer, peripheral
ulcerative keratitis |
Ulcus rodens
Corneae or Mooren's ulcer has been described as an agonizing, unrelenting,
unabating ulcerative keratitis that initiates from peripheral cornea and then
enlarges circumferentially and centrally. If primarily location of ulcer is at the periphery of the
cornea and there is no separation, it becomes an indicator to investigate for
collagen vascular diseases. The general
ophthalmologist needs to be meticulous if the peripheral corneal disease has
the following characteristics: if the epithelium is not intact, if there is
some loss of stroma, if it is a real keratitis and inflammation is present, if
white blood cells have infiltrated into the peripheral cornea. The fact
to keep in mind is that PUK is a diagnosis of exclusion.
A 36 year old male presented with chief
complaints of foreign body sensation watering, redness, diminished vision
ocular pain and photophobia in both eyes for last 2 months. The symptoms were
pronounced OD with excruciating pain since last two weeks. No history of
ocular or systemic disease however could be elicited.
Ocular
examination revealed a visual acuity of 6/9 OD and 6/6 OS. Ocular examination demonstrated a 360 degree circumferential zone of scarring and
ectasia of the right cornea but no associated scleritis.
Scarring and neovascularization encroached upon but did not obscure visual
axis. 360 degree circumferential area of scarring and ectasia of cornea was
also present in left eye.
On
examination right eye revealed a perforated Mooren ulcer with uveal tissue
herniation at 4-5 o’clock position. In both eyes, an undermined overhanging
edge with grey white opacification and extending centrally and
circumferentially could be appreciated. The pupil revealed peaking nasally OD
due to impending uveal tissue herniation. No hypopyon or AC cells could be
discovered on examination. Dilated Indirect ophthalmoscopy revealed no
abnormality. There was no history of trauma or joint pain or systemic disease.
Circumcorneal congestion was present. Extraocular
movements were full OU. Posterior segment examination in both eyes was
inconclusive.
A
battery of investigations was conducted which included – Complete Heamogram
with ESR, X-ray chest and small Joints, Urine routine and microscopy, VDRL, RA
factor, ANCA (antinuclear cytoplasmic antibodies), ANA (antinuclear
antibodies), HBSAG (hepatitis b surface antigen), SGPT, HCV (hepatitis c
virus). Scraping of the ulcer were done, which was inconclusive. Finally a diagnosis of Bilateral Mooren’s
Fig. 1: 360 degree
circumferential zone of scarring and ectasia
of the left cornea.
Fig. 2: 360 degree circumferential zone of scarring and thinning of right
cornea but no associated scleritis with perforation at 4 -5 oclock, partially epithelised.
ulcer
was made and systemic immunosuppressive therapy was started in terms of oral
methotrexate 10 mg once a week and oral prednisone 1 mg / kg / day. Bandage
Contact Lens was applied in right eye and conjunctival recession was performed.
DISCUSSION
Mooren's ulcer also known as chronic
serpiginous ulcer of cornea has been defined as an entity with cascade of
unknown events existing in absolute absence of any ocular infection or systemic
rhematological diseases accountable for the ongoing devastation of the cornea.
It has been recognized as an immensely destructive corneal lesion starting from
corneal periphery and spreading centrally centrifugally and Posteriorly. Absence of scleritis is
of substantial importance. Precise pathophysiology still remains unknown,
although evidences suggest cell mediated and humoral immune mechanisms as a
basis of pathogenesis. Though many modern approaches have been devised in step
approach management of Moorens ulcer, notable amount of cases are recalcitrant
to accessible treatments and end in severe visual morbidity.
Presenting complaints in Mooren's ulcer usually are redness,
epiphora, and Photophobia, but excruciating agony out of proportion to
inflammation is typically the prominent feature. Related iritis, central
corneal involvement and irregular astigmatism due to peripheral corneal ectasia
may lead to decreased visual acuity. The disease begins with many variegated,
peripheral stromal infiltrates that merge later on, more frequently in the
medial and lateral quadrants than in the superior and inferior ones. This is
followed by formation of epithelial defect and a shallow furrow in this area1.
Involvement of anterior one-third to one-half of the stroma occurs
typically with a sloping, overhanging edge. This is followed by healing and
vascularization with the lesion gradually taking its course in 4 – 18 months.
Iritis, glaucoma, cataract and very rarely hypopyon are associated with Moorens
ulcer2.
The ulceration encompasses corneal periphery leaving a central
island of oedematous opacified cornea else progresses transversely and
relentlessly replaces stroma with thin scar tissue. Corneal perforation is a
much common occurrence in MU leading to visual morbidity.
The adjacent scleral and DM tissue is largerly spared3.
On the basis of clinical presentation and
the low-dose anterior segment fluorescein angiographic findings, Mooren's ulcer
has been classified into three main types: Unilateral Mooren's ulcer is usually recognized as excessively
painful progressive keratitis in elder age group in this variety of MU
superficial vascular plexus of the anterior segment remains non-perfused. Bilateral aggressive Mooren's
ulceration (BAM), clinical entity more frequent in young individuals,
progresses circumferentially and, only later, centrally in the cornea.
Angiography shows vascular leakage and new vessel formation at the base of the
ulcer.
Bilateral indolent Mooren's
ulceration (BIM) common in middle-age group patients results in progressive
peripheral corneal guttering in both eyes, with minimal inflammatory response.
vascular architecture is usually normal
on angiography with an exception that extension of new vessels into the
ulcer may be noted4,5.
If one uses a fine instrument to explore the ulcer, one will find
that it has an overhanging lip; if this fine instrument is exploring the ulcer
toward the center of the cornea, one can be absolutely astonished at how far
into the cornea the instrument can go before it meets resistance. In other
words, there's a lot more destruction than is clinically apparent at the slit
lamp.
The systemic evaluation should not discover that the patient has
an elevated C-reactive protein, an elevated sedimentation rate, auto-antibody
production of any type but particularly antineutrophil cytoplasmic
antibody."
Moorens
ulcer has been linked with different systemic entities including toxoplasma,
hepatitis B and C, herpes simplex and zoster, syphilis, TB and intestinal
hookworm1,2 histopathology of Mooren’s ulcer reveals increased
number of antigen-presenting cells, mast cells and immunoglobulins6.
Bilateral Mooren’s ulcer as seen in our case is frequently found in Indian
subcontinent and in patches of West Africa. The age group most commonly
involved is 14 – 40. They may present with unilateral typical lesion in one eye
but soon may develop lesion in the other eye. Angiography reveals altered
architecture of episcleral vessels along with some areas of closure. There are
no changes in conjunctiva but the angiogram reflects a breakup of the limbal
arcade, extension of the vessels into the ulcer bed and leaky vessel tips. This
variety has a tendency to perforate spontaneously and if not paid attention can
lead to significant visual morbidity7.
CONCLUSION
Bilateral
Mooren’s ulcer in young population needs to be given an immediate attention as
visual morbidity remains significant in this variety. Only if the aggressive systemic evaluation turns out inconclusive
and the adjacent sclera is not involved, it's appropriate to hang the label
Mooren's ulcer. Aggressive systemic immunomodulatory medication is absolute if
cause of patient's PUK is discovered to be a consequence of polyarteritis nodosa
or microscopic polyangiitis and granulomatosis with polyangiitis.
Author’s Affiliation
Dr. Tarun sood
M.S. Ophthalmology (IGMC Shimla)
Eye Surgeon
Civil Hospital Sarkaghat
Himachal
Pardesh, India
Dr. Mandeep Tomar
Registrar
RPGMC Tanda
Himachal Pardesh
Deptt
of Ophthalmology
Dr. Anuj Sharma
MD Dermatology
Zonal Hospital,
Bilaspur
Himachal
Pardesh
Dr. Ravinder K Gupta
Prof. and Head
MS Ophthalmology
Igmc Shimla
Role of Authors
Dr. Tarun sood
Diagnosis and managing the case.
Dr. Mandeep Tomar
Managing the case and photography.
Dr. Anuj Sharma
Managing the case and editing the final write–up.
Dr. Ravinder K Gupta
Managing the case and editing the final write–up.
REFERENCES
1.
Frangieh
T, Kenyon K. Mooren's ulcer. In: Brightbill FS, ed. Corneal Surgery: Theory,
technique, and tissue, ed 2. St Louis: Mosby, 1993: 328-335.
2.
Keitzman
B. Mooren's ulcer in Nigeria. Am J Ophthalmol. 1968; 65: 679-685.
3.
Muthaiah SrinivasanMichael
E Zegans Joseph R Zelefsky. Clinical characteristics of Mooren’s ulcer in
South India. .
4.
Watson PG.
Management of Mooren's ulceration. Eye
1997; 11: 349–356.
5.
Lewallen
S, Courtright P. Problems with current concepts of the epidemiology of Mooren's
corneal ulcer. Ann Ophthalmol. 1990; 22: 52-55.
6.
Foster CS.
Mooren’s ulcer following salmonella gastroenteritis. Massachusetts Eye and Ear
Infirmary Immunology Service, 1999.
7.
Keitzman B.
Moorens ulcer in Nigeria. AM J Ophthalmol. 1986; 65: 679-85.